These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 6210096)

  • 1. Studies of anti-F(ab')2 antibodies and possible immunologic control mechanisms in systemic lupus erythematosus.
    Silvestris F; Bankhurst AD; Searles RP; Williams RC
    Arthritis Rheum; 1984 Dec; 27(12):1387-96. PubMed ID: 6210096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active systemic lupus erythematosus is associated with depletion of the natural generic anti-idiotype (anti-F(ab')2) system.
    Williams RC; Malone CC; Huffman GR; Silvestris F; Croker BP; Ayoub EM; Massengill S
    J Rheumatol; 1995 Jun; 22(6):1075-85. PubMed ID: 7674233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Auto-anti-anti-DNA antibodies from SLE patients and normals.
    Taniguchi O; Chia DS; Barnett EV
    J Rheumatol; 1984 Jun; 11(3):291-7. PubMed ID: 6610752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Family distribution of anti-F(ab')2 antibodies in relatives of patients with systemic lupus erythematosus.
    Silvestris F; Searles RP; Bankhurst AD; Williams RC
    Clin Exp Immunol; 1985 May; 60(2):329-38. PubMed ID: 3874025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-reactivity of human IgG anti-F(ab')2 antibody with DNA and other nuclear antigens.
    Williams RC; Malone CC; Cimbalnik K; Presley MA; Roux KH; Strelets L; Silvestris F
    Arthritis Rheum; 1997 Jan; 40(1):109-23. PubMed ID: 9008607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shared V-region antigens and cross-reacting specificities of human IgG anti-F(ab')2 and anti-DNA antibodies.
    Williams RC; Malone CC; Silvestris F
    Clin Immunol Immunopathol; 1996 Aug; 80(2):194-203. PubMed ID: 8764565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fixation of complement by anti-F(ab')2 antibodies or ssDNA when added to systemic lupus erythematosus sera.
    Shrier DA; Taniguchi O; Barnett EV
    J Rheumatol; 1984 Apr; 11(2):182-7. PubMed ID: 6610052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parallelism of serum anti-F(ab')2 and anti-cationic IgG reactivities in patients with systemic lupus erythematosus.
    Silvestris F; Yancey WB; Malone C; Searles R; Dammacco F; Williams RC
    Clin Immunol Immunopathol; 1991 May; 59(2):256-70. PubMed ID: 2009644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro inhibition of anti-DNA producing cells from systemic lupus erythematosus patients by autologous anti-F(ab')2 antibodies.
    Silvestris F; Williams RC; Frassanito MA; Dammacco F
    Clin Immunol Immunopathol; 1987 Jan; 42(1):50-62. PubMed ID: 3491713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of anti-F(ab')2 antibodies and the 16/6 idiotype in systemic lupus erythematosus (SLE) probands and kindreds.
    Silvestris F; Searles RA; Williams RC; Rodriguez MA; Schwartz RS
    J Clin Immunol; 1989 Nov; 9(6):462-8. PubMed ID: 2698398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiidiotypic antibodies against anti-DNA antibodies in sera of families of lupus patients.
    Abdou NI; Suenaga R; Hatfield M; Evans M; Hassanein KM
    J Clin Immunol; 1989 Jan; 9(1):16-21. PubMed ID: 2784794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDR molecular localization of possible anti-idiotypic anti-DNA antibodies in normal subjects, patients with SLE, and SLE first-degree relatives.
    Williams RW; Malone CC; Silvestris F
    J Lab Clin Med; 1995 Jul; 126(1):44-56. PubMed ID: 7602233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of human anti-idiotypes broadly cross reactive with anti-dsDNA antibodies from patients with Systemic lupus erythematosus.
    Zhang W; Winkler T; Kalden JR; Reichlin M
    Scand J Immunol; 2001 Feb; 53(2):192-7. PubMed ID: 11169224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of anti-F(ab')2 antibodies in SLE patients. Evidence for cross-reacting auto-anti-idiotypic antibodies.
    Nasu H; Chia DS; Taniguchi O; Barnett EV
    Clin Immunol Immunopathol; 1982 Oct; 25(1):80-90. PubMed ID: 6983943
    [No Abstract]   [Full Text] [Related]  

  • 15. Naturally occurring anti-idiotypic antibodies reactive with anti-DNA antibodies in systemic lupus erythematosus.
    Williams WM; Isenberg DA
    Lupus; 1998; 7(3):164-75. PubMed ID: 9607640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-idiotypic antibody against anti-DNA in sera of laboratory personnel exposed to lupus sera or nucleic acids.
    Hatfield M; Evans M; Suenaga R; Hassanein KM; Abdou NI
    Clin Exp Immunol; 1987 Oct; 70(1):26-34. PubMed ID: 3500815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG anti-F(ab')2 antibodies from SLE patients react with immunodominant residues in kappa CDRs, but show reduced C kappa region reactivity.
    Williams RC; Malone CC; Roemer JH; Silvestris F; Solomon A
    Clin Immunol Immunopathol; 1995 Dec; 77(3):366-73. PubMed ID: 7586748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human anti-F(ab')2 antibodies show preferential reactivity for F(ab')2 molecules bearing lambda light chains.
    Yancey WB; Silvestris F; Conlon M; Rodriguez M; Malone C; Williams RC
    Clin Immunol Immunopathol; 1992 Nov; 65(2):176-82. PubMed ID: 1395132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies against human anti-F(ab')2 antibodies react with light chain epitopes.
    Silvestris F; Rots N; Yancey WB; Malone C; Searles R; Solomon A; Dammacco F; Williams RC
    Clin Immunol Immunopathol; 1991 Apr; 59(1):139-55. PubMed ID: 1708314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-idiotypic antibodies prevent the serologic detection of antiribosomal P autoantibodies in healthy adults.
    Pan ZJ; Anderson CJ; Stafford HA
    J Clin Invest; 1998 Jul; 102(1):215-22. PubMed ID: 9649575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.